🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 35 of 114

  1. Febuxostat IR

    Takeda

    Gout

    phase 3 small molecule completed

    2 trials

  2. Felzartamab

    Biogen

    Immunoglobulin A Nephropathy (IgAN)

    phase 3 small molecule active

    1 trial

  3. Femara 2.5 mg film-coated tablets, Cisplatin 1 mg/ml Concentrate for Solution for Infusion, Anastrozole 1mg film-coated tablets, Docetaxel Pfizer 10 mg/mL concentrate for solution for infusion, Paclitaxel 6 mg/ml Concentrate for Solution for Infusion, Exemestane 25 mg Film-coated Tablets, Carboplatin 10 mg/ml Concentrate for Solution for Infusion, Abraxane 5 mg/ml powder for dispersion for infusion.

    Ningbo Cancer Hospital

    low-grade serous carcinoma of the ovary or peritoneum

    phase 3 small molecule active

    1 trial

  4. Fenofibrate

    Xijing Hospital of Digestive Diseases

    Primary Biliary Cirrhosis

    phase 3 small molecule active

    1 trial

  5. Fentanyl Buccal Tablet

    Teva Pharma GmbH

    Chronic Pain

    phase 3 small molecule completed

    1 trial

  6. Fentanyl Buccal Tablets

    Teva Pharma GmbH

    Pain

    phase 3 small molecule terminated

    1 trial

  7. Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone

    Teva Pharma GmbH

    Chronic Pain

    phase 3 small molecule completed

    1 trial

  8. Ferric Citrate 1 GM Oral Tablet [AURYXIA]

    Akebia Europe Limited

    Anemia, Iron Deficiency

    phase 3 small molecule completed

    1 trial

  9. Fezolinetant

    Astellas Pharma Inc

    Hot Flashes

    phase 3 small molecule completed

    1 trial

  10. Fianlimab

    Regeneron UK Limited

    Melanoma

    phase 3 small molecule active

    3 trials

  11. Fianlimab, LIBTAYO 350 mg concentrate for solution for infusion., Placebo for Fianlimab

    Lacuna Pharma Pty Ltd

    Advanced Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  12. Fibrinogen (human) + thrombin (human) (TachoSil)

    Takeda

    Surgical Resection of Superficial Renal Tumour

    phase 3 other completed

    1 trial

  13. Ficerafusp alfa

    Bicara Therapeutics

    Metastatic Head and Neck Squamous Cell Carcinoma

    phase 3 small molecule active

    1 trial

  14. Filgotinib

    Lakefront Biotherapeutics NV

    Ankylosing Spondylitis

    phase 3 small molecule terminated

    3 trials

  15. Filgotinib

    Lakefront Biotherapeutics NV

    Crohn's Disease

    phase 3 small molecule completed

    2 trials

  16. Filgotinib

    Alfasigma S.p.A.

    Axial Spondyloarthritis

    phase 3 small molecule active

    1 trial

  17. Filgotinib

    Lakefront Biotherapeutics NV

    Ulcerative Colitis

    phase 3 small molecule completed

    2 trials

  18. Filgotinib

    Lakefront Biotherapeutics NV

    Psoriatic Arthritis

    phase 3 small molecule terminated

    4 trials

  19. Film-Coated Tablet without Deucravacitinib, Film-Coated Tablet without JNJ-77242113, DEUCRAVACITINIB, JNJ-77242113

    Janssen-Cilag International N.V.

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  20. Film-Coated Tablet without JNJ-77242113, JNJ-77242113

    Janssen-Cilag International N.V.

    Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  21. Fimasartan and Rosuvastatin

    Yung NA

    Essential Hypertension, Dyslipidemia

    phase 3 small molecule completed

    1 trial

  22. Finerenone (BAY94-8862)

    Bayer HealthCare AG

    Heart Failure

    phase 3 small molecule completed

    1 trial

  23. Finerenone (BAY94-8862)

    Bayer HealthCare AG

    Diabetic Kidney Disease

    phase 3 small molecule completed

    1 trial

  24. Finerenone (BAY94-8862)

    Bayer HealthCare AG

    Chronic Kidney Disease

    phase 3 small molecule completed

    1 trial

  25. Finerenone Bayer, Placebo BAY 948862, BAY 94-8862, Placebo BAY 948862 tablets, Finerenone, Finerenone

    Bayer AG

    Heart failure due to systemic left ventricular systolic dysfunction

    phase 3 small molecule active

    1 trial

  26. Finerenone, BAY 94-8862, BAY 948862, Finerenone Bayer

    Bayer AG

    Treatment of children with chronic kidney disease and proteinuria

    phase 3 small molecule active

    1 trial

  27. Finerenone, Finerenone Bayer, BAY 94-8862, Finerenone

    Bayer AG

    Heart failure due to systemic left ventricular systolic dysfunction

    phase 3 small molecule active

    1 trial

  28. Finerenone, Placebo, Placebo, BAY 94-8862

    Bayer AG

    Non-diabetic chronic kidney disease

    phase 3 small molecule active

    1 trial

  29. Fingolimod

    Novartis Pharmaceuticals

    Multiple Sclerosis (MS)

    phase 3 small molecule active

    1 trial

  30. Fingolimod placebo, FINGOLIMOD, Ublituximab Placebo, ublituximab

    TG THERAPEUTICS, INC.

    Relapsing Multiple Sclerosis

    phase 3 small molecule active

    1 trial

  31. Finished Herbal Product such as Suan Tsao Jen Tang, Jia-Wey Shiau-Yau San

    Hospital Authority, Hong Kong

    Menopausal Women

    phase 3 small molecule active

    1 trial

  32. Firibastat

    Quantum Biopharma

    Hypertension

    phase 3 small molecule completed

    1 trial

  33. Firibastat (QGC001) Period 1

    Quantum Biopharma

    Hypertension (HTN)

    phase 3 small molecule terminated

    1 trial

  34. Firmonertinib

    ArriVent BioPharma

    Non-Small-Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  35. Firmonertinib

    ArriVent BioPharma

    NSCLC

    phase 3 small molecule active

    1 trial

  36. Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)

    Hoffmann-La Roche

    Early Breast Cancer

    phase 3 small molecule completed

    1 trial

  37. Flecainide or Sotalol or Propafenone

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    phase 3 small molecule completed

    1 trial

  38. Flomoxef

    Takeda

    Urinary Tract Infection

    phase 3 small molecule terminated

    1 trial

  39. FluLaval® Quadrivalent

    GlaxoSmithKline

    Influenza

    phase 3 mab completed

    1 trial

  40. Flublok Quadrivalent vaccine

    Hospital Authority, Hong Kong

    Influenza Vaccination

    phase 3 mab completed

    1 trial

  41. Flucelvax Tetra - suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures), PNEUMOVAX solution injectable en flacon Vaccin pneumococcique polyosidique, Pneumovax 23 oldatos injekció előretöltött fecskendőben Pneumococcus-poliszacharid vakcina, BOOSTRIX, suspension injectable en seringue préremplie Vaccin diphtérique, tétanique et coquelucheux (acellulaire multicomposé), (adsorbé, à teneur réduite en antigènes), Pneumovax 23 oldatos injekció e

    Novartis Pharmaceuticals

    Relapsing multiple sclerosis (RMS)

    phase 3 small molecule active

    1 trial

  42. Fludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion

    AXIM BIOTECHNOLOGIES, INC.

    B-cell Acute Lymphoblastic Leukemia

    phase 3 small molecule active

    1 trial

  43. Fluoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  44. Fluticasone Propionate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  45. Fluticasone Propionate and Salmeterol Inhalation Powder

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  46. Fluticasone Propionate, 880 mcg twice daily (after 6FED failure)

    Ultragenyx UK Limited

    Eosinophilic Gastrointestinal Disorders (EGIDs)

    phase 3 small molecule completed

    1 trial

  47. Fluticasone furoate

    GlaxoSmithKline

    Rhinitis

    phase 3 small molecule completed

    1 trial

  48. Fluticasone propionate

    Teva Pharma GmbH

    Seasonal Allergic Rhinitis

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.